The New York Genome Center (NYGC) is an independent, nonprofit academic research institution that serves as a multi-institutional hub for genomic research. Leveraging our strengths in whole-genome sequencing and genomic analysis, our mission is the advancement of genomic science and its application to drive novel biomedical discoveries. NYGC’s areas of focus include the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease.
In light of need for researchers worldwide to collaborate to defeat COVID-19, we are also now applying our expertise in genomics and our role as the scientific convener in New York to help accelerate and support COVID-19 genomics research. In March 2020, NYGC Evnin Family Scientific Director and Chief Executive Officer Tom Maniatis, PhD, convened area researchers and other interested parties representing both our Institutional Founding Members and others, and the COVID-19 Genomics Research Network was launched.
The NYGC harnesses the expertise and builds on the combined strengths of our faculty, member institutions, scientific working groups, affiliate members, and industry partners to advance genomic discovery. Central to our scientific mission is an outstanding faculty who lead independent research labs based at the NYGC, and hold tenure-track joint appointments with one of our member institutions.
The NYGC has attracted leading scientists whose wide-ranging expertise — including single cell genomics, genome engineering, population genomics, statistical genetics, computational biology and bioengineering — brings a multidisciplinary and in-depth approach to the field of genomics. NYGC senior and core faculty members, who hold joint appointments at leading New York institutions, include a Nobel Laureate, three Lasker award winners and five members of the National Academy of Sciences. Since its inception, NYGC researchers have published more than 200 research studies in leading, high-impact scientific journals.